CDMOAvid Bioservices, Inc.

Nasdaq avidbio.com


$ 11.31 $ 0.13 (1.16 %)    

Monday, 16-Sep-2024 15:59:58 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 11.29
$ 11.20
$ 11.28 x 100
$ 11.31 x 300
$ 11.14 - $ 11.40
$ 4.07 - $ 11.57
605,632
na
720.25M
$ 1.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-09-2024 07-31-2024 10-Q
2 07-02-2024 04-30-2024 10-K
3 04-24-2024 01-31-2024 10-Q
4 12-07-2023 10-31-2023 10-Q
5 09-07-2023 07-31-2023 10-Q
6 06-21-2023 04-30-2023 10-K
7 03-13-2023 01-31-2023 10-Q
8 12-06-2022 10-31-2022 10-Q
9 09-06-2022 07-31-2022 10-Q
10 06-29-2022 04-30-2022 10-K
11 03-08-2022 01-31-2022 10-Q
12 12-07-2021 10-31-2021 10-Q
13 09-08-2021 07-31-2021 10-Q
14 06-29-2021 04-30-2021 10-K
15 03-08-2021 01-31-2021 10-Q
16 12-02-2020 10-31-2020 10-Q
17 09-01-2020 07-31-2020 10-Q
18 06-30-2020 04-30-2020 10-K
19 03-10-2020 01-31-2020 10-Q
20 12-09-2019 10-31-2019 10-Q
21 09-05-2019 07-31-2019 10-Q
22 06-27-2019 04-30-2019 10-K
23 03-11-2019 01-31-2019 10-Q
24 12-10-2018 10-31-2018 10-Q
25 09-10-2018 07-31-2018 10-Q
26 07-16-2018 04-30-2018 10-K
27 03-12-2018 01-31-2018 10-Q
28 12-11-2017 10-31-2017 10-Q
29 09-11-2017 07-31-2017 10-Q
30 07-14-2017 04-30-2017 10-K
31 03-13-2017 01-31-2017 10-Q
32 12-12-2016 10-31-2016 10-Q
33 09-08-2016 07-31-2016 10-Q
34 07-14-2016 04-30-2016 10-K
35 03-09-2016 01-31-2016 10-Q
36 12-10-2015 10-31-2015 10-Q
37 09-09-2015 07-31-2015 10-Q
38 07-14-2015 04-30-2015 10-K
39 03-12-2015 01-31-2015 10-Q
40 12-10-2014 10-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-maintains-outperform-on-avid-bioservices-raises-price-target-to-12

RBC Capital analyst Sean Dodge maintains Avid Bioservices (NASDAQ:CDMO) with a Outperform and raises the price target from $...

 stephens--co-reiterates-overweight-on-avid-bioservices-maintains-12-price-target

Stephens & Co. analyst Jacob Johnson reiterates Avid Bioservices (NASDAQ:CDMO) with a Overweight and maintains $12 price...

 william-blair-reiterates-market-perform-on-avid-bioservices

William Blair analyst Max Smock reiterates Avid Bioservices (NASDAQ:CDMO) with a Market Perform.

 avid-bioservices-q1-2025-adj-eps-003-beats-006-estimate-sales-4017m-miss-4076m-estimate

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0....

 why-avid-bioservices-stock-is-moving-higher-wednesday

Avid reported fourth quarter financial results on Tuesday after the market closed. The company reported a loss of $1.94 per sha...

 rbc-capital-reiterates-outperform-on-avid-bioservices-maintains-8-price-target

RBC Capital analyst Sean Dodge reiterates Avid Bioservices (NASDAQ:CDMO) with a Outperform and maintains $8 price target.

 avid-bioservices-q4-2024-gaap-eps-194-vs-004-estimate-sales-43000m-beat-42142m-estimate

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(1.94) per share which missed the analyst consensus estimate of $(...

 rbc-capital-maintains-outperform-on-avid-bioservices-raises-price-target-to-8

RBC Capital analyst Sean Dodge maintains Avid Bioservices (NASDAQ:CDMO) with a Outperform and raises the price target from $...

 avid-bioservices-q3-2024-gaap-eps-009-misses-005-estimate-sales-33800m-beat-33452m-estimate

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(...

 stephens--co-maintains-overweight-on-avid-bioservices-lowers-price-target-to-12

Stephens & Co. analyst Jacob Johnson maintains Avid Bioservices (NASDAQ:CDMO) with a Overweight and lowers the price tar...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION